Rep. McClain Delaney Discloses Sale of Transdigm Group Shares

WASHINGTON — U.S. Representative April McClain Delaney, a Democrat from Maryland, sold shares in Transdigm Group Inc. valued between $100,001 and $250,000 on August 25, according to a new financial disclosure filed with the House of Representatives.

The transaction, reported on September 11, 2026, involves the aerospace parts manufacturer based in Cleveland, Ohio. The sale falls within the standard reporting categories for congressional stock transactions, which require lawmakers to disclose trades made within specific timeframes after they occur. McClain Delaney, who represents Maryland's 3rd Congressional District, did not specify the exact number of shares sold or the precise price per share in the initial filing, adhering to the broad valuation bands mandated by federal ethics rules.

Transdigm Group is a major supplier of aftermarket parts and systems for commercial and military aircraft. The company has been a subject of legislative interest regarding defense spending and aviation safety regulations, areas where McClain Delaney has served on relevant committees. While the disclosure confirms the sale took place, it does not provide details regarding the motivation behind the trade or whether the transaction was part of a pre-planned diversification strategy.

The filing aligns with the Stock Act of 2012, which prohibits members of Congress from trading individual stocks for personal profit based on non-public information. The law requires strict reporting to ensure transparency in congressional financial activities. This specific disclosure adds to the growing record of stock trades by members of the 119th Congress, as lawmakers navigate portfolio management alongside their legislative duties.

No immediate comment was available from McClain Delaney's office regarding the sale. The representative has not publicly addressed the transaction in recent press conferences or social media statements. Ethics officials have not indicated any irregularities with the filing at this time.

Questions remain regarding the broader context of the trade, including whether similar transactions occurred among other members of the House Armed Services Committee or the Transportation and Infrastructure Committee, both of which oversee sectors relevant to Transdigm's operations. Additionally, it is unclear if the sale was part of a larger liquidation event or an isolated adjustment to the representative's investment portfolio.

The disclosure serves as a public record for constituents and watchdog groups monitoring potential conflicts of interest in Washington. As the 2026 legislative session continues, scrutiny of congressional financial dealings remains a focal point for transparency advocates. Further details on the transaction may emerge if additional filings are submitted or if the representative chooses to elaborate on her investment decisions in future communications.